Global Energy Drink Market Overview - GlobalData forecasts an 8.0% compound annual growth rate (CAGR) for global off-trade retail sales of energy drinks through 2030[8] - The U S non-alcoholic ready-to-drink beverage market achieved $122 billion in retail sales over the most recent 52-week period[18] - The U S market for non-alcoholic ready-to-drink beverages sold 36 3 billion units at retail over the most recent 52-week period[22] Monster Energy Company (MEC) Distribution and Market Share - Monster is now distributed in 138 countries and territories[7] - Strategic Brands are now distributed in 57 countries and territories[7] - Reign is now distributed in 27 countries and territories[7] - Affordable Energy (Predator & Fury) is now distributed in 36 countries and territories[7] - One or more of the company's energy drinks are distributed in a total of 158 countries and territories worldwide[7] - MEC holds a 34 7% value share in the United States and a 36 3% value share in Canada[17] EMEA & OSP Region Performance - The energy category in EMEA & OSP shows value sales of €15 3 billion, with a €1 9 billion increase versus the prior year, representing a 14 4% growth[55] - MEC's value sales in EMEA & OSP are €3 8 billion, with a €695 million increase versus the prior year, representing a 22 7% growth[55] - Monster brand value sales in EMEA & OSP are €2 9 billion, with a €537 million increase versus the prior year, representing a 22 4% growth[55] Latin America Beverage Market - The Latin American market for non-alcoholic ready-to-drink beverages is forecasted to generate approximately $144 billion in retail sales in 2025[123] - Energy drinks in Latin America have a $ CAGR (2020-2025) of 21 6%[128] - Monster maintains $ share leadership in Brazil with 43 8%[140]

AI Transformation & Collaborative Work Management - Asana is positioning itself as the platform for human + AI collaboration, emphasizing context, checkpoints, and controls [18, 20, 22, 24] - The company is introducing AI Teammates, collaborative AI agents designed to deliver real outcomes [36] - AI Studio is designed to supercharge workflows and accelerate outcomes [28] - Early traction of AI Studio and AI Teammates has led to over $1 million in bookings in the first full quarter (Q1), with sequential growth in Q2 and Q3 [55] Financial Performance & Growth - Total revenue for the trailing twelve months (TTM) is $774 million, with a TTM revenue growth of 9% [68] - Non-GAAP gross margin stands at 89% [68] - Customer growth from customers spending $100K+ annually is 15% year-over-year [69, 80] - The company repurchased $30.8 million of Class A common stock in Q3'26, representing 22 million shares [92] - Asana is guiding for FY26 revenue between $789 million and $791 million, representing 9% revenue growth [94] - The FY26 non-GAAP operating margin is expected to be 7% [88, 94]

Third Quarter 2025 Performance - The company's operating income increased by 6% to $113 million, based on revenue of $136 billion[29] - Comparable sales increased by 4%[28] - Aerie's comparable sales increased by 11%[28] - Earnings per diluted share (EPS) were $053[28] - The company repurchased shares totaling $231 million in the first half of the year, including $21 million this quarter, and returned $64 million in cash dividends year-to-date[29] Fiscal Year 2025 Outlook - The company anticipates comparable sales to be up in the low single digits[30] - The company expects operating income to be between $303 million and $308 million on an adjusted basis[30] - The company projects depreciation and amortization to be approximately $216 million[30] Inventory - Ending inventory increased by 11% to $891232 thousand compared to the previous year[39]

Financial Performance - The company reported revenue of $244 million, representing a 25% year-over-year growth rate[7, 41] - The Q3 FY26 Non-GAAP operating margin was 18%[7, 41] - The Q3 FY26 Non-GAAP adjusted free cash flow margin was 11%[7, 41] - Adjusted Free Cash Flow was $27 million[41] - The company's dollar-based net retention rate was 119%[7] - The company has provided revenue guidance for Q4 FY2026 of $2510 million to $2520 million and full fiscal year 2026 revenue guidance of $946 million to $947 million[52] Customer Base - The company has 10,475 base customers[7] - The company has 1,405 customers with over $100K in ARR[7] - 54% of total ARR is from GitLab Ultimate as of Q3 FY26[15] Product and Recognition - GitLab Ultimate is the company's AI-native enterprise-grade DevSecOps solution[15] - GitLab received Gartner recognition in the 2025 Magic Quadrant for DevOps Platforms and AI Code Assistants[20, 21]

Bank of America Leveraged Finance Presentation Curt Begle - Chief Executive Officer Jim Till- Chief Financial Officer Robert Weilminster – EVP Investor Relations 1 December 2025 Safe Harbor Statements and Important Information Magnera Corporation (NYSE: MAGN) serves 1,000+ customers worldwide, offering a wide range of material solutions, including components for absorbent hygiene products, protective apparel, wipes, specialty building and construction products, and products serving the food and beverage ind ...

UBS GLOBAL INDUSTRIALS & JIM VENA – CHIEF EXECUTIVE OFFICER JENNIFER HAMANN – CHIEF FINANCIAL OFFICER KENNY ROCKER – EVP MARKETING & SALES UNION PACIFIC CORPORATION TRANSPORTATION CONFERENCE UP-NS Merger: Path to Completion The Board of Directors of both Union Pacific and Norfolk Southern have unanimously approved the transaction STB application anticipated to be filed before the end of the year; analyst conference call to follow Transaction subject to obtaining Surface Transportation Board ("STB") approval ...

BANK OF AMERICA LEVERAGED FINANCE CONFERENCE DECEMBER 2025 © 2025 OPTION CARE HEALTH, INC. ALL RIGHTS RESERVED Disclaimers Forward-Looking Statements This presentation may contain "forward-looking statements" within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements can be identified by words such as: "anticipate," "intend," "plan," "believe," "project," "estimate," "expect," "may," "should," "will" and similar references to fut ...

Oral Small Molecule Splicing Platform - PTC pioneered small molecule splicing therapies, with Evrysdi approved in over 100 countries and votoplam in development for Huntington's disease[21] - Small molecules enhance U1 interaction, increasing exon inclusion to generate distinct mRNA transcripts and modulate protein expression, exemplified by votoplam (PTC518)[22, 25, 29, 30] - PTC's PTSeek screening technology, leveraging learnings from SMA and HD programs, enables the discovery of novel sequence-selective 5' splice site enhancers for iExons[48, 96, 98] - PTC has discovered iExons throughout the entire transcriptome, covering a majority of genes, allowing for the targeting of splicing for novel small molecule enhancers[89, 90, 91] Splicing Platform Programs - MSH3 program targets nucleotide repeat disorders like Huntington's disease, with 30-50% MSH3 lowering stalling expansion in a human somatic expansion model[111, 129] - Spinocerebellar Ataxia 3 (SCA3) program aims to lower mutant ATXN3 protein production by inducing exon skipping[132, 141, 142] - Oncology program targets a key protein in cancer biology, with novel splicing modulators selectively inducing mRNA decay[147, 152] - Hemoglobinopathies program targets regulators of fetal hemoglobin (HbF) levels, with novel splicing modulators lowering a validated target of HbF induction[158, 163, 165] Inflammation & Ferroptosis Platform - PTC's inflammation and ferroptosis platform targets specialized enzyme hubs to regulate inflammation, energy production, and oxidative stress[179] - Parkinson's Disease program targets 15-LO to prevent ferroptosis-mediated cell death and alpha-synuclein aggregation[181, 183, 188] - PTC612, a highly selective NLRP3 inhibitor, demonstrates significant reduction in inflammatory cytokines and pathology across multiple preclinical models, with an IC50 of 099 nM in THP-1 cells[225, 227, 234]

Financial Performance - ITT reported Q3 2025 revenue of $999.1 million, a 12.9% increase compared to $885.2 million in Q3 2024[31] - Organic revenue growth for Q3 2025 was 6.1%[31] - Adjusted EPS for Q3 2025 was $1.78, a 21.1% increase compared to $1.47 in Q3 2024[43] - Free cash flow for Q3 2025 was $154.1 million, a 77% increase compared to $87.3 million in Q3 2024[17,53] - The company raised its full-year adjusted EPS guidance to a range of $6.62 to $6.68[16] Segment Performance (2024 Revenue) - Motion Technologies (MT) reported $1.4478 billion in revenue[26] - Industrial Process (IP) reported $1.361 billion in revenue[26] - Connect & Control Technologies (CCT) reported $825.1 million in revenue[26] Growth Metrics - The company achieved a 9% organic revenue CAGR and a 13% adjusted EPS CAGR over a 3-year period[11] - Average ROIC was 15%[11] - Total Shareholder Return (TSR) was +45%, outperforming the S&P 500 by +1,600 bps[11] Full Year 2024 vs 2021 (Organic) - Organic revenue grew by $805.3 million, a 30% increase[26] - Organic orders grew by $767.2 million, a 27% increase[28] Full Year 2025 Guidance - The company expects approximately $3.87 billion in revenue[53] - The company expects approximately $500 million in free cash flow[16,53]

Financial Performance - Q1 FY26 - Net sales decreased slightly by 0.4% to $7,840 million compared to $7,871 million in Q1 FY25 [14] - Adjusted EBITDA increased significantly by 24.6% to $167 million from $134 million in Q1 FY25 [14] - Adjusted EPS grew substantially by 250% to $0.56 from $0.16 in Q1 FY25 [14] - Free cash flow improved from $(159) million to $(54) million [14] Strategic Initiatives and Operational Efficiency - Network optimization actions reduced total net sales growth by approximately 3% [15, 24] - Net leverage ratio decreased to 3.2x, down 1.0x year-over-year [30] - Net debt decreased by $331 million year-over-year to $1,897 million [30] - Lean daily management was deployed at 34 out of 49 distribution centers by the end of the quarter [19] - New item setup time was reduced by 50% at the Chesterfield, NH Distribution Center [44] Fiscal Year 2026 Outlook - The company affirmed its fiscal 2026 outlook, including net sales of $31.6 - $32.0 billion and adjusted EBITDA of $630 - $700 million [36]